ET

Area of Science:

• Nephrology
• Immunology
• Cardiovascular Research

Background:

• Acute kidney injury (AKI) and renal ischemia-reperfusion (IR) injury are linked to hypertension development.
• T cells are implicated in the mechanisms connecting AKI to hypertension.
• Endothelin, primarily via the ETA receptor, is known to promote T cell infiltration in various diseases.

Purpose of the Study:

• To investigate the role of ETA receptor activation in promoting T cell infiltration into the kidney following IR injury.
• To determine if blocking the ETA receptor can mitigate T cell infiltration post-renal IR injury.

Main Methods:

• Male C57BL/6 mice were treated with an ETA receptor antagonist (ABT-627) or vehicle.
• Mice underwent unilateral renal IR injury.
• Renal tissue was analyzed at 24 hours and 10 days post-IR for injury and T cell infiltration (CD3+ cells, RORγt expression).

Main Results:

• Endothelin-1 (ET-1) was upregulated in injured kidneys post-IR in both groups.
• ABT-627 treatment significantly reduced CD3+ T cell infiltration in the outer medulla (35%) and cortex (23%) at 10 days post-IR.
• Outer medullary RORγt expression, a T helper 17 marker, was reduced by ABT-627 treatment.

Conclusions:

• Endothelin-1, acting through the ETA receptor, contributes to T cell infiltration in the kidney after IR injury.
• Targeting the ETA receptor may be a strategy to manage immune-mediated long-term consequences of AKI.
• Further research is needed to explore the specific T cell subsets involved and long-term implications.